Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kwonjune Justin Seung, M.D.


The Ugunja Peace Center: Community health wrokers and primary care in rural Kenya
International, 05/24/09 - 07/14/09

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Oza S, Chen F, Selser V, Clougherty MM, Dale KD, Iberg Johnson J, Brock-Fisher T, Seung KJ, Bourdeaux M. Community-Based Outbreak Investigation And Response: Enhancing Preparedness, Public Health Capacity, And Equity. Health Aff (Millwood). 2023 03; 42(3):349-356. PMID: 36877907.
    Citations:    Fields:    Translation:HumansPHPublic Health
  2. Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood S, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binedgie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2023 Feb 21. PMID: 36802336.
    Citations:    Fields:    
  3. Zeng C, Mitnick CD, Hewison C, Bastard M, Khan P, Seung KJ, Rich ML, Atwood S, Melikyan N, Morchiladze N, Khachatryan N, Khmyz M, Restrepo CG, Salahuddin N, Kazmi E, Dahri AA, Ahmed S, Varaine F, Vilbrun SC, Oyewusi L, Gelin A, Tintaya K, Yeraliyeva LT, Hamid S, Khan U, Huerga H, Franke MF. Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):34-40. PMID: 36853128; PMCID: PMC9879081.
    Citations:    Fields:    Translation:Humans
  4. Huerga H, Khan U, Bastard M, Mitnick CD, Lachenal N, Khan PY, Seung KJ, Melikyan N, Ahmed S, Rich ML, Varaine F, Osso E, Rashitov M, Salahuddin N, Salia G, Sánchez E, Serobyan A, Rafi Siddiqui M, Grium Tefera D, Vetushko D, Yeghiazaryan L, Holtzman D, Islam S, Kumsa A, Jacques Leblanc G, Leonovich O, Mamsa S, Manzur-Ul-Alam M, Myint Z, Padayachee S, Franke MF, Hewison C. Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs. Clin Infect Dis. 2022 10 12; 75(8):1307-1314. PMID: 35243494; PMCID: PMC9555840.
    Citations:    Fields:    Translation:Humans
  5. Hewison C, Khan U, Bastard M, Lachenal N, Coutisson S, Osso E, Ahmed S, Khan P, Franke MF, Rich ML, Varaine F, Melikyan N, Seung KJ, Adenov M, Adnan S, Danielyan N, Islam S, Janmohamed A, Karakozian H, Kamene Kimenye M, Kirakosyan O, Kholikulov B, Krisnanda A, Kumsa A, Leblanc G, Lecca L, Nkuebe M, Mamsa S, Padayachee S, Thit P, Mitnick CD, Huerga H. Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort. Clin Infect Dis. 2022 09 29; 75(6):1006-1013. PMID: 35028659; PMCID: PMC9522425.
    Citations: 3     Fields:    Translation:Humans
  6. Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95. Int J Infect Dis. 2022 Aug; 121:105. PMID: 35613479.
    Citations:    Fields:    
  7. Seung KJ, Franke MF, Hewison C, Huerga H, Khan U, Mitnick CD. Corrigendum to 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029]. J Hepatol. 2022 Aug; 77(2):583. PMID: 35581037.
    Citations:    Fields:    
  8. Khan PY, Franke MF, Hewison C, Seung KJ, Huerga H, Atwood S, Ahmed S, Khan M, Sultana T, Manzur-Ul-Alam M, Vo LNQ, Lecca L, Yae K, Kozhabekov S, Tamirat M, Gelin A, Vilbrun SC, Kikvidze M, Faqirzai J, Kadyrov A, Skrahina A, Mesic A, Avagyan N, Bastard M, Rich ML, Khan U, Mitnick CD. All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings. Eur Respir J. 2022 01; 59(1). PMID: 34140298.
    Citations: 2     Fields:    Translation:Humans
  9. Wroe EB, Seung KJ, Baker BK, Farmer PE. Test and treat: a missing link in the global fight against COVID-19. Lancet Glob Health. 2022 02; 10(2):e181-e182. PMID: 34953515; PMCID: PMC8694701.
    Citations: 6     Fields:    Translation:HumansCells
  10. Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, Bonnet M, Chang E, Cloez S, Coit JM, Cox V, de Jong BC, Delifer C, Do JM, Tozzi DDS, Ducher V, Ferlazzo G, Gouillou M, Khan A, Khan U, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moschioni M, O'Brien K, Okunbor O, Oyewusi L, Panda S, Patil SB, Phillips PPJ, Pichon L, Rupasinghe P, Rich ML, Saluhuddin N, Seung KJ, Tamirat M, Trippa L, Cellamare M, Velásquez GE, Wasserman S, Zimetbaum PJ, Varaine F, Mitnick CD. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial. Trials. 2021 Sep 25; 22(1):651. PMID: 34563240.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
    Citations: 1     
  12. Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S91-S95. PMID: 33823277.
    Citations: 1     Fields:    Translation:Humans
  13. Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, Rich ML, Zarli K, Samieva N, Oyewusi L, Nair P, Mudassar M, Melikyan N, Lenggogeni P, Lecca L, Kumsa A, Khan M, Islam S, Hussein K, Docteur W, Chumburidze N, Berikova E, Atshemyan H, Atwood S, Alam M, Ahmed S, Bastard M, Mitnick CD. Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study. Am J Respir Crit Care Med. 2021 01 01; 203(1):111-119. PMID: 32706644; PMCID: PMC7781121.
    Citations: 16     Fields:    Translation:Humans
  14. Seung KJ, Khan U, Varaine F, Ahmed S, Bastard M, Cloez S, Damtew D, Franke MF, Herboczek K, Huerga H, Islam S, Karakozian H, Khachatryan N, Kliesckova J, Khan AJ, Khan M, Khan P, Kotrikadze T, Lachenal N, Lecca L, Lenggogeni P, Maretbayeva S, Melikyan N, Mesic A, Mitnick CD, Mofolo M, Perrin C, Richard M, Tassew YM, Telnov A, Vilbrun SC, Wanjala S, Rich ML, Hewison C. Introducing new and repurposed TB drugs: the endTB experience. Int J Tuberc Lung Dis. 2020 10 01; 24(10):1081-1086. PMID: 33126943.
    Citations: 2     Fields:    Translation:Humans
  15. Lachenal N, Hewison C, Mitnick C, Lomtadze N, Coutisson S, Osso E, Ahmed S, Leblanc G, Islam S, Atshemyan H, Nair P, Kholikulov B, Aiylchiev S, Zarli K, Adnan S, Krisnanda A, Padayachee S, Stambekova A, Sahabutdinova Y, de Guadalupe S, Moreno P, Kumsa A, Reshid A, Makaka J, Abebe S, Melikyan N, Seung KJ, Khan U, Khan P, Huerga H, Rich M, Varaine F. Setting up pharmacovigilance based on available endTB Project data for bedaquiline. Int J Tuberc Lung Dis. 2020 10 01; 24(10):1087-1094. PMID: 33126944.
    Citations: 2     Fields:    Translation:Humans
  16. Seung KJ, Khan P, Franke MF, Ahmed S, Aiylchiev S, Alam M, Putri FA, Bastard M, Docteur W, Gottlieb G, Hewison C, Islam S, Khachatryan N, Kotrikadze T, Khan U, Kumsa A, Lecca L, Tassew YM, Melikyan N, Naing YY, Oyewusi L, Rich M, Wanjala S, Yedilbayev A, Huerga H, Mitnick CD. Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis. Clin Infect Dis. 2020 07 11; 71(2):415-418. PMID: 31676905.
    Citations: 5     Fields:    Translation:HumansCells
  17. Seung KJ, Franke MF, Hewison C, Huerga H, Khan U, Mitnick CD. High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients. J Hepatol. 2020 05; 72(5):1028-1029. PMID: 32147086.
    Citations: 3     Fields:    Translation:Humans
  18. Khan U, Huerga H, Khan AJ, Mitnick CD, Hewison C, Varaine F, Bastard M, Rich M, Franke MF, Atwood S, Khan PY, Seung KJ. The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infect Dis. 2019 Aug 20; 19(1):733. PMID: 31429722; PMCID: PMC6701145.
    Citations: 12     Fields:    Translation:Humans
  19. Seung KJ, Hewison C. Now is the time for shorter all-oral regimens for multidrug-resistant tuberculosis. Lancet Glob Health. 2019 06; 7(6):e706. PMID: 31005492.
    Citations: 4     Fields:    Translation:Humans
  20. Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834. PMID: 30215381; PMCID: PMC6463280.
    Citations: 198     Fields:    Translation:Humans
  21. Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 09 01; 198(5):657-666. PMID: 29954183; PMCID: PMC6118011.
    Citations: 36     Fields:    Translation:HumansCellsCTClinical Trials
  22. Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2018 04; 6(4):265-275. PMID: 29595509; PMCID: PMC9017096.
    Citations: 31     Fields:    Translation:Humans
  23. Park KB, Khan U, Seung K. Open letter to The Global Fund about its decision to end DPRK grants. Lancet. 2018 03 31; 391(10127):1257. PMID: 29550024.
    Citations: 1     Fields:    Translation:Humans
  24. Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC Infect Dis. 2016 08 27; 16(1):453. PMID: 27567500; PMCID: PMC5002098.
    Citations: 13     Fields:    Translation:Humans
  25. Seung KJ, Franke M, Linton SW. Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible? PLoS Med. 2016 08; 13(8):e1002062. PMID: 27483430; PMCID: PMC4970717.
    Citations: 7     Fields:    Translation:Humans
  26. Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, Menzies D, Ahuja S, Ashkin D, Avendaño M, Banerjee R, Bauer M, Burgos M, Centis R, Cobelens F, Cox H, D'Ambrosio L, de Lange WCM, DeRiemer K, Enarson D, Falzon D, Flanagan K, Flood J, Gandhi N, Garcia-Garcia L, Granich RM, Hollm-Delgado MG, Holtz TH, Hopewell P, Iseman M, Jarlsberg LG, Kim HR, Lancaster J, Lange C, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Narita M, Nathanson E, Odendaal R, O'Riordan P, Pai M, Palmero D, Park SK, Pena J, Pérez-Guzmán C, Ponce-de-Leon A, Quelapio MID, Quy HT, Riekstina V, Royce S, Salim M, Schaaf HS, Seung KJ, Shah L, Shean K, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Sung SW, Tabarsi P, Tupasi TE, Vargas MH, van Altena R, van der Walt M, van der Werf TS, Westenhouse J, Yew WW. Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. Clin Infect Dis. 2016 Apr 01; 62(7):887-895. PMID: 26757804.
    Citations: 24     Fields:    Translation:Humans
  27. Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27; 5(9):a017863. PMID: 25918181; PMCID: PMC4561400.
    Citations: 113     Fields:    Translation:Humans
  28. Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis. 2014 Nov 15; 59(10):1364-74. PMID: 25097082; PMCID: PMC4296130.
    Citations: 57     Fields:    Translation:Humans
  29. Vasan A, Ellner A, Lawn SD, Gove S, Anatole M, Gupta N, Drobac P, Nicholson T, Seung K, Mabey DC, Farmer PE. Integrated care as a means to improve primary care delivery for adults and adolescents in the developing world: a critical analysis of Integrated Management of Adolescent and Adult Illness (IMAI). BMC Med. 2014 Jan 14; 12:6. PMID: 24423387.
    Citations: 11     Fields:    Translation:Humans
  30. Vasan A, Ellner A, Lawn SD, Gupta N, Anatole M, Drobac P, Nicholson T, Gove S, Seung K, Mabey D, Farmer P. Strengthening of primary-care delivery in the developing world: IMAI and the need for integrated models of care. Lancet Glob Health. 2013 Dec; 1(6):e321-3. PMID: 25104589.
    Citations: 5     Fields:    Translation:Humans
  31. Seung KJ, Becerra MC, Atwood SS, Alcántara F, Bonilla CA, Mitnick CD. Salvage therapy for multidrug-resistant tuberculosis. Clin Microbiol Infect. 2014 May; 20(5):441-6. PMID: 23991934.
    Citations: 7     Fields:    Translation:HumansCells
  32. Seung KJ, Linton SW. The growing problem of multidrug-resistant tuberculosis in North Korea. PLoS Med. 2013; 10(7):e1001486. PMID: 23935457.
    Citations: 14     Fields:    Translation:HumansCells
  33. Satti H, McLaughlin MM, Seung KJ. Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho. Am J Trop Med Hyg. 2013 Jul; 89(1):174-7. PMID: 23669229; PMCID: PMC3748478.
    Citations: 5     Fields:    Translation:Humans
  34. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664. PMID: 23516529.
    Citations: 31     Fields:    Translation:Humans
  35. Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2013 Jan; 17(1):100-6. PMID: 23232009.
    Citations: 7     Fields:    Translation:Humans
  36. Satti H, McLaughlin MM, Hedt-Gauthier B, Atwood SS, Omotayo DB, Ntlamelle L, Seung KJ. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho. PLoS One. 2012; 7(10):e46943. PMID: 23115633.
    Citations: 31     Fields:    Translation:Humans
  37. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300. PMID: 22952439.
    Citations: 215     Fields:    Translation:Humans
  38. Satti H, Motsamai S, Chetane P, Marumo L, Barry DJ, Riley J, McLaughlin MM, Seung KJ, Mukherjee JS. Comprehensive approach to improving maternal health and achieving MDG 5: report from the mountains of Lesotho. PLoS One. 2012; 7(8):e42700. PMID: 22952607.
    Citations: 16     Fields:    Translation:Humans
  39. Satti H, McLaughlin MM, Omotayo DB, Keshavjee S, Becerra MC, Mukherjee JS, Seung KJ. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PLoS One. 2012; 7(5):e37114. PMID: 22629356.
    Citations: 13     Fields:    Translation:Humans
  40. Satti H, Mafukidze A, Jooste PL, McLaughlin MM, Farmer PE, Seung KJ. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho. Int J Tuberc Lung Dis. 2012 Apr; 16(4):468-72. PMID: 22326109.
    Citations: 20     Fields:    Translation:Humans
  41. Seung KJ, Rigodon J, Finch M, Gove S, Vasan A, Satti H. Distribution of adult respiratory illnesses at a primary health centre in Lesotho. Int J Tuberc Lung Dis. 2012; 16(3):418-22. PMID: 22640456.
    Citations: 3     Fields:    Translation:Humans
  42. Seung KJ. Does my patient have multidrug-resistant tuberculosis? Clin Infect Dis. 2010 Aug 15; 51(4):379-80. PMID: 20624063.
    Citations: 1     Fields:    Translation:Humans
  43. Kam KM, Sloutsky A, Yip CW, Bulled N, Seung KJ, Zignol M, Espinal M, Kim SJ. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance. Int J Tuberc Lung Dis. 2010 Mar; 14(3):282-8. PMID: 20132618.
    Citations: 20     Fields:    Translation:HumansCells
  44. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One. 2009 Sep 25; 4(9):e7186. PMID: 19779624.
    Citations: 58     Fields:    Translation:HumansCells
  45. Vasan A, Kenya-Mugisha N, Seung KJ, Achieng M, Banura P, Lule F, Beems M, Todd J, Madraa E. Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda. Hum Resour Health. 2009 Aug 20; 7:75. PMID: 19695083.
    Citations: 19     Fields:    
  46. Seung KJ, Bitalabeho A, Buzaalirwa LE, Diggle E, Downing M, Bhatt Shah M, Tumwebaze B, Gove S. Standardized patients for HIV/AIDS training in resource-poor settings: the expert patient-trainer. Acad Med. 2008 Dec; 83(12):1204-9. PMID: 19202501.
    Citations: 7     Fields:    Translation:Humans
  47. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74. PMID: 18687637; PMCID: PMC2673722.
    Citations: 117     Fields:    Translation:HumansCells
  48. Satti H, Seung K, Keshavjee S, Furin J. Extensively drug-resistant tuberculosis, Lesotho. Emerg Infect Dis. 2008 Jun; 14(6):992-3. PMID: 18551748.
    Citations: 7     Fields:    Translation:HumansCells
  49. Furin JJ, Rigodon J, Cancedda C, Keshavjee S, Seung KJ, Letsie M, Kim JY, Joseph JK. Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho. Int J Tuberc Lung Dis. 2007 Oct; 11(10):1154-6. PMID: 17945074.
    Citations: 3     Fields:    Translation:Humans
  50. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6. PMID: 16562709.
    Citations: 6     Fields:    Translation:Humans
  51. Han LL, Sloutsky A, Canales R, Naroditskaya V, Shin SS, Seung KJ, Timperi R, Becerra MC. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens. Int J Tuberc Lung Dis. 2005 Jul; 9(7):818-21. PMID: 16013781.
    Citations: 15     Fields:    Translation:Humans
  52. Seung KJ. Should isoniazid and clofazimine be used to treat multidrug-resistant tuberculosis? Int J Tuberc Lung Dis. 2005 Feb; 9(2):231-2; author reply 232. PMID: 15732749.
    Citations:    Fields:    Translation:Humans
  53. Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, Sirotkina OB, Yanova GV, Strelis AK. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis. 2004 Nov 01; 39(9):1321-8. PMID: 15494909.
    Citations: 35     Fields:    Translation:Humans
  54. Seung KJ, Joseph K, Hurtado R, Rich M, Shin S, Furin J, Leandre F, Mukherjee J, Farmer P. Number of drugs to treat multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004 Jun 15; 169(12):1336-7; author reply 1337. PMID: 15187016.
    Citations: 2     Fields:    Translation:Humans
  55. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Int J Tuberc Lung Dis. 2004 Mar; 8(3):361-8. PMID: 15139476.
    Citations: 27     Fields:    Translation:Humans
  56. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004 Feb 07; 363(9407):474-81. PMID: 14962530.
    Citations: 94     Fields:    Translation:Humans
  57. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis. 2003 Oct; 7(10):912-9. PMID: 14552560.
    Citations: 14     Fields:    Translation:Humans
  58. Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003 Jul; 7(7):637-44. PMID: 12870684.
    Citations: 11     Fields:    Translation:Humans
  59. Shin S, Guerra D, Rich M, Seung KJ, Mukherjee J, Joseph K, Hurtado R, Alcantara F, Bayona J, Bonilla C, Farmer P, Furin J. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis. 2003 Apr 15; 36(8):996-1003. PMID: 12684912.
    Citations: 19     Fields:    Translation:HumansCells
  60. Marker PC, Seung K, Bland AE, Russell LB, Kingsley DM. Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice. Genetics. 1997 Feb; 145(2):435-43. PMID: 9071596.
    Citations: 20     Fields:    Translation:AnimalsCells
  61. King JA, Marker PC, Seung KJ, Kingsley DM. BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol. 1994 Nov; 166(1):112-22. PMID: 7958439.
    Citations: 53     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Seung's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (188)
Co-Authors (32)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.